**Core Concept**
The clinical presentation suggests a muscular dystrophy, characterized by progressive muscle weakness and degeneration. The key **muscular dystrophy** features include elevated serum **creatine kinase** levels and muscle biopsy findings of **necrosis**, **myophagocytosis**, and **regenerating fibers**.

**Why the Correct Answer is Right**
The described symptoms and biopsy results are characteristic of **Duchenne muscular dystrophy (DMD)**, which is caused by mutations in the **dystrophin** gene. DMD leads to the absence or severe deficiency of the **dystrophin protein**, resulting in muscle fiber instability and degeneration. The variation in muscle fiber size and presence of **fibrosis** are hallmarks of the disease.

**Why Each Wrong Option is Incorrect**
**Option A:** This choice is incorrect because the primary issue in DMD is not related to **dystroglycan** mutations, although dystroglycan interacts with dystrophin in the muscle cell membrane.
**Option B:** This option is incorrect as **merosin** (laminin alpha-2) deficiencies are associated with a different form of muscular dystrophy.
**Option C:** This choice is incorrect because **sarcoglycan** mutations are linked to another type of muscular dystrophy.

**Clinical Pearl / High-Yield Fact**
Duchenne muscular dystrophy is an X-linked recessive disorder, primarily affecting males, with a key diagnostic feature being significantly elevated **creatine kinase** levels. The disease progression is relentless, leading to severe disability.

**Correct Answer:** D. dystrophin